A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca reports Imfinzi plus chemotherapy significantly improved pathologic complete response in gastric and gastroesophageal junction cancers in Phase 3 trial; about 1 million new patients were diagnosed with gastric cancer in 2020
Published: June 02, 2023 by AstraZeneca AB
Pfizer reports positive results in Phase 3 trial of antibiotic combination to treat serious bacterial infections caused by Gram-negative bacteria, including multidrug-resistant pathogens; drug is potential treatment for mutidrug-resistant infections
Published: June 01, 2023 by Pfizer Inc.
Pfizer reports its experimental injectable hemophilia drug marstacimab reduced bleeding frequency without safety concerns in Phase 3 study; marstacimab works by shutting down a protein that impedes blood clotting
Published: May 31, 2023 by BioPharma Dive
Janssen and Bristol Myers' Milvexian granted FDA fast track designation for all three indications under evaluation in Phase 3 Librexia program; indications include ischemic stroke, acute coronary syndrome and atrial fibrillation
Published: May 25, 2023 by Johnson & Johnson Services Inc.
AstraZeneca's Tagrisso plus chemotherapy shows statistically significant PFS improvement in epidermal growth factor receptor-mutated advanced non-small cell lung cancer in Phase 3 trial
Published: May 17, 2023 by dpa-AFX International Compact

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count